Category

Extended Release Tablet Of Antidiabetic Drug

 

Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

 
₹ 4,165

Availability: Out of stock

 

Delivery :

Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description
 

According to WHO 2012 report 347 million people worldwide have Diabetes. Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. Glipizide has a relatively short elimination half-life (2–4 h) and practically water-insoluble BCS class-II drug thereby requiring two to three times daily dosing in large number of patients, which often leads to non-compliance. The present work was aimed towards the development of extended release formulations of glipizide in order to achieve plasma concentration profile up to 24 hrs using based on matrix technology resulting in a better patient compliance. Limited work has been performed and published on hydroxy ethyl cellulose and hydroxyl propyl cellulose as an oral extended release hydrophilic matrix system. This book is helpful to the researcher who works with development of extended release matrix tablet formulations using hydroxy ethyl cellulose and hydroxy propyl cellulose.

Product Specifications
SKU :COC85201
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
0 Review(s)